Stay updated on Rapastinel Adjunct in Depression Clinical Trial
Sign up to get notified when there's something new on the Rapastinel Adjunct in Depression Clinical Trial page.

Latest updates to the Rapastinel Adjunct in Depression Clinical Trial page
- Check3 days agoChange DetectedThe footer revision label changed from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedA 403 Forbidden error now appears on the study page, with the 403 message and site header/footer visible, indicating access is blocked rather than new study information being added.SummaryDifference17%

- Check45 days agoChange DetectedRevision from v3.6.5 to v3.6.6 is now displayed on the page, reflecting a minor metadata update. It does not modify the study details, eligibility criteria, or outcomes.SummaryDifference0.0%

- Check59 days agoChange DetectedDeleted three items: the directive to check AllerganClinicalTrials.com for study locations and the IR contact email; the sponsor line naming Naurex, Inc.; and the 'Helpful Links Provided by' heading.SummaryDifference0.1%

- Check66 days agoChange DetectedThe page revision was updated from 3.6.4 to 3.6.5, indicating a small update to the page's documentation. This usually reflects minor fixes or clarifications without changing study content or functionality.SummaryDifference0.0%

- Check81 days agoChange DetectedThe page now includes a note directing users to AllerganClinicalTrials.com for nearby study locations and provides a contact email for assistance. The revision note has been updated from v3.6.3 to v3.6.4.SummaryDifference0.1%

Stay in the know with updates to Rapastinel Adjunct in Depression Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Rapastinel Adjunct in Depression Clinical Trial page.